Timby's Introductory Medical-Surgical Nursing Thirteenth, North American Edition - Caring for Clients With Orthopedic and Connective Tissue Disorders Related

Review Timby's Introductory Medical-Surgical Nursing Thirteenth, North American Edition - Caring for Clients With Orthopedic and Connective Tissue Disorders related questions and content

The nurse is discussing the new medication that a client will be taking for treatment of rheumatoid arthritis. Which disease-modifying antirheumatic drug (DMARD) will the nurse educate the client about?

  • A. Methotrexate
  • B. Celecoxib
  • C. Methylprednisolone
  • D. Mercaptopurine azathioprine
Correct Answer: A

Rationale: Methotrexate is a DMARD that reduces the amount of joint damage and slows the damage to other tissues as well. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID). Methylprednisolone is a steroid to reduce pain and inflammation and slow joint destruction. Mercaptopurine azathioprine is a cytotoxic drug.